While Neumora Therapeutics Inc. has underperformed by -5.53%, investors are advised to look at stock chart patterns for technical insight.
On December 12, 2023, Deutsche Bank started tracking Neumora Therapeutics Inc. (NASDAQ: NMRA) recommending Hold. A report published by William Blair on October 10, 2023, Initiated its previous ‘Outperform’ rating for NMRA. Stifel also rated NMRA shares as ‘Buy’, setting a target price of $26 on the company’s shares in an initiating report dated October 10, 2023. RBC Capital Mkts Initiated an Outperform rating on October 10, 2023, and assigned a price target of $24. JP Morgan initiated its ‘Overweight’ rating for NMRA, as published in its report on October 10, 2023. Guggenheim’s report from October 10, 2023 suggests a price prediction of $22 for NMRA shares, giving the stock a ‘Buy’ rating. BofA Securities also rated the stock as ‘Buy’.
Analysis of Neumora Therapeutics Inc. (NMRA)
One of the most important indicators of Neumora Therapeutics Inc.’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -54.49% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 19.05, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and NMRA is recording 543.18K average volume. On a monthly basis, the volatility of the stock is set at 7.72%, whereas on a weekly basis, it is put at 7.76%, with a loss of -14.12% over the past seven days. Furthermore, long-term investors anticipate a median target price of $24.71, showing growth from the present price of $9.06, which can serve as yet another indication of whether NMRA is worth investing in or should be passed over.
How Do You Analyze Neumora Therapeutics Inc. Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 66.63%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 14.98% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
NMRA shares are owned by institutional investors to the tune of 14.98% at present.
